Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;22(4):620-3.
doi: 10.1038/cr.2012.25. Epub 2012 Feb 7.

Defining the expressed breast cancer kinome

Alicia A Midland  1 , Martin C Whittle, James S Duncan, Amy N Abell, Kazuhiro Nakamura, Jon S Zawistowski, Lisa A Carey, H Shelton Earp 3rd, Lee M Graves, Shawn M Gomez, Gary L Johnson
Affiliations

Defining the expressed breast cancer kinome

Alicia A Midland et al. Cell Res. 2012 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
RNA-seq reads for five cell lines were aligned to human genome 19 (HG19) transcripts using Bowtie. The overlap of protein kinases with greater than 50 aligned reads each showed that most kinases were found to be in all cell lines and few kinases were found to be unique to a specific cell line.
See this image and copyright information in PMC

References

    1. Walker I, Newell H. Do molecularly targeted agents in oncology have reduced attrition rates. Nat Rev Drug Discov. 2009;8:15–16. - PubMed
    1. Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9:28–39. - PubMed
    1. Fedorov O, Muller S, Knapp S. The (un)targeted cancer kinome. Nat Chem Biol. 2010;6:166–169. - PubMed
    1. Weinstein IB, Joe AK. Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol. 2006;3:448–457. - PubMed
    1. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011;9:16–32. - PubMed

Publication types

Substances